Related Experiment Video

Updated: Jul 7, 2026

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

Parkinson's disease and motor-neuron disease in former prisoners-of-war

W F Page, C M Tanner

    Lancet (London, England)
    |March 11, 2000
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
    14:27

    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

    Published on: June 26, 2013

    In Vivo Protocol of Controlled Subconcussive Head Impacts for the Validation of Field Study Data
    06:14

    In Vivo Protocol of Controlled Subconcussive Head Impacts for the Validation of Field Study Data

    Published on: April 18, 2019

    Related Experiment Videos

    Last Updated: Jul 7, 2026

    Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
    08:29

    Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

    Published on: October 10, 2012

    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
    14:27

    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

    Published on: June 26, 2013

    In Vivo Protocol of Controlled Subconcussive Head Impacts for the Validation of Field Study Data
    06:14

    In Vivo Protocol of Controlled Subconcussive Head Impacts for the Validation of Field Study Data

    Published on: April 18, 2019

    Related Concept Videos

    Disorders of the Nervous Tissue01:28

    Disorders of the Nervous Tissue

    Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
    Homeostatic Imbalances:
    Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
    Parkinson's disease arises from the...
    Post-traumatic Stress Disorder01:27

    Post-traumatic Stress Disorder

    Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
    Symptoms and Behavioral Manifestations
    A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events, are a...

    Articles linked to this work by shared authors, journal, and citation graph.

    Incidence of Parkinson disease in North America.

    NPJ Parkinson's disease·2022

    Prevalence of Parkinson's disease across North America.

    NPJ Parkinson's disease·2018

    Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

    Movement disorders : official journal of the Movement Disorder Society·2017

    Marinesco bodies and substantia nigra neuron density in Parkinson's disease.

    Neuropathology and applied neurobiology·2017

    Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.

    Journal of the neurological sciences·2011

    Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease.

    European journal of neurology·2011

    Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

    Lancet (London, England)·2026

    Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

    Lancet (London, England)·2026

    Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

    Lancet (London, England)·2026

    First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

    Lancet (London, England)·2026

    Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

    Lancet (London, England)·2026

    14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

    Lancet (London, England)·2026

    Chlamydia and gonorrhoea testing and positivity among women prescribed opioid agonist therapy in Australia.

    Sexual health·2026

    Evaluating the Impact of Analgesic Guidelines on Opioid Prescribing for Facial Local Flap Reconstruction.

    Ear, nose, & throat journal·2026

    Sedative Potential of L (+)-Tartaric Acid: Behavioral Evidence With In Silico Insights Into Possible GABAergic Interaction.

    Brain and behavior·2026

    Long-term safety profile of opicapone in patients with Parkinson's disease and early fluctuations.

    Frontiers in neurology·2026

    Ginsenoside Re attenuates severe acute pancreatitis-associated acute lung injury by inhibiting pancreatic necroptosis-driven cfDNA release and pulmonary cGAS-STING activation.

    Journal of ginseng research·2026

    Potentially harmful excipients in drugs: an analysis of labeling practices and adverse drug reactions.

    Frontiers in pharmacology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us